EUPRAXIA PHARMACEUTICALS INC
EPRXNASDAQEarnings Nov 11US Equity
$6.44▼ $0.25 (−3.96%)
Live1h▼ 1.5%
24h▼ 4.0%
7d▼ 0.7%
14d▲ 8.0%
30d▲ 0.3%
1y▲ 19.4%
🏦Market Cap
$418M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
63
Fair
📊
Analyst Ratings
Price
$6.44
Total
2
Raised
0
Lowered
0
Avg PT
$17.00
H / L
$17 / $17
| Institution | Action | Rating | Date |
|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-05-04 |
Cantor Fitzgerald | Reiterated | Overweight | 2026-01-15 |
One row per institution, most recent rating